Trial Details
COMPLETEDBasic Information
| Clinical ID | c865 |
|---|---|
| Identifier | NCT05913817 |
| Trial Title | The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Ulcerative Colitis|Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Plaque Psoriasis|Hidradenitis Suppurativa |
| Interventions | BIOLOGICAL: AVT02 (Alvotech Biosimilar to Adalimumab) |
Participant Information
| Sponsor | Jamp Pharma Corporation |
|---|---|
| City | Quebec |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2023-01-09 |
|---|---|
| Primary Completion Date | 2025-07-31 |
| Completion Date | 2025-08-25 |